Aridis Pharmaceuticals, Inc. ( ARDS) - Key Metrics
ARDS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0.01 | $0 | -$0.03 | -$0.03 |
| 2023Q2 | $0.54 | $0.34 | -$0.12 | -$0.12 |
| 2023Q1 | ? | -$0.24 | -$0.13 | -$0.13 |
| 2022Q4 | ? | -$0.24 | -$0.39 | -$0.39 |
| 2022Q3 | ? | -$0.51 | -$0.24 | -$0.24 |
ARDS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | ? | -11.51 |
| 2023Q2 | ? | 0.16 |
| 2023Q1 | ? | -0.33 |
| 2022Q4 | ? | -1.21 |
| 2022Q3 | ? | -0.45 |
ARDS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q3 | -25.72% | ? |
| 2023Q2 | -54.74% | ? |
| 2023Q1 | -41.89% | ? |
| 2022Q4 | -33.14% | ? |
| 2022Q3 | -25.91% | ? |
ARDS
Price: $0
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -0.01
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 543871
Market Capitalization: 8915